- Home
- PGEN vs EOSE Comparison
PGEN vs EOSE Comparison
Compare PGEN & EOSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PGEN | EOSE |
|---|---|---|
| Founded | 1998 | 2008 |
| Country | United States | United States |
| Employees | N/A | 787 |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | PGEN | EOSE |
|---|---|---|
| Price | $6.25 | $3.39 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 7 |
| Target Price | $8.33 | ★ $9.42 |
| AVG Volume (30 Days) | 3.7M | ★ 24.7M |
| Earning Date | 05-13-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $230,981,000.00 | N/A |
| Revenue This Year | $1,115.92 | $172.02 |
| Revenue Next Year | $81.04 | $97.32 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.70 | $3.11 |
| 52 Week High | $6.04 | $19.86 |
Technical Indicators
Market Signals| Indicator | PGEN | EOSE |
|---|---|---|
| Relative Strength Index (RSI) | 65.51 | 32.83 |
| Support Level | $3.96 | N/A |
| Resistance Level | $6.04 | $8.15 |
| Average True Range (ATR) | 0.31 | 0.36 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 79.59 | 14.24 |
Price Performance
Historical ComparisonAbout PGEN Precigen Inc.
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
About EOSE Eos Energy Enterprises Inc.
Eos Energy Enterprises Inc designs develop, manufactures, and markets zinc-based energy storage solutions for utility-scale, microgrid, and commercial & industrial (C&I) applications. The solutions are used in the utility sector, the renewable energy sector, and the industrial sector.